Drug intelligence / Profile preview

Laxabon

Development stage
Unknown
Lead developer
Karo Healthcare
Modality
Small Molecules
Administration
Oral
01

Overview

Laxabon is a high-volume, polyethylene glycol (PEG)-based osmotic laxative solution used for total bowel cleansing prior to colonoscopy, radiological examinations, or colonic surgery. Marketed primarily in Sweden, it consists of Macrogol 3350 (PEG) combined with an electrolyte balance (sodium sulfate, sodium chloride, potassium chloride, and sodium bicarbonate) designed to minimize net fluid and electrolyte exchange across the intestinal wall. The mechanism of action involves the osmotic retention of water within the intestinal lumen, which increases stool volume and triggers peristalsis, effectively purging the colon. In clinical research conducted by the Karolinska Institutet, Laxabon served as the standard-of-care traditional bowel preparation in trials evaluating whether nutritional drinks (like Fresubin) could provide a better-tolerated alternative for patients, particularly those with cardiovascular or renal conditions sensitive to electrolyte shifts.

Brand names
Laxabon
Other names
PEG-ELSPolyethylene glycol 3350 with electrolytesMacrogol 3350 plus electrolytesMacrogol3350 plus electrolytesMacrogol-3350 plus electrolytes

Beyond the preview

Go deeper on Laxabon.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Laxabon.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call